Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Oct;104(2):327–330. doi: 10.1111/j.1476-5381.1991.tb12430.x

Methylxanthine-induced attenuation of pecking in chickens.

M R Zarrindast 1, T Nasir 1
PMCID: PMC1908538  PMID: 1797301

Abstract

1. Apomorphine induced dose-dependent pecking in chickens. 2. The response was decreased by theophylline or caffeine in a dose-dependent manner. 3. Administration of theophylline or caffeine alone did not exert any effect on pecking behaviour. 4. Dipyridamole administration neither induced pecking nor altered the pecking induced by apomorphine. 5. Administration of 5-N-ethylcarboxamide-adenosine to animals caused variable effects on pecking induced by apomorphine. The drug did not induce pecking by itself. 6. It is concluded that the inhibitory response to methylxanthines may be mediated through blockade of adenosine receptors. However, to prove this, more experiments are needed.

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbuthnott G. W., Attree T. J., Eccleston D., Loose R. W., Martin M. J. Is adenylate cyclase the dopamine receptor? Med Biol. 1974 Oct;52(5):350–353. [PubMed] [Google Scholar]
  2. Brunelli M., Magni F., Moruzzi G., Musumeci D. Apomorphine pecking in the pigeon. Arch Ital Biol. 1975 Dec;113(4):303–325. [PubMed] [Google Scholar]
  3. Bruns R. F., Lu G. H., Pugsley T. A. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol. 1986 Apr;29(4):331–346. [PubMed] [Google Scholar]
  4. Carney J. M. Effects of caffeine, theophylline and theobromine on scheduled controlled responding in rats. Br J Pharmacol. 1982 Mar;75(3):451–454. doi: 10.1111/j.1476-5381.1982.tb09161.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cheng H. C., Long J. P. Dopaminergic nature of apomorphine-induced pecking in pigeons. Eur J Pharmacol. 1974 May;26(2):313–320. doi: 10.1016/0014-2999(74)90242-8. [DOI] [PubMed] [Google Scholar]
  6. Choi O. H., Shamim M. T., Padgett W. L., Daly J. W. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci. 1988;43(5):387–398. doi: 10.1016/0024-3205(88)90517-6. [DOI] [PubMed] [Google Scholar]
  7. DESHPANDE V. R., SHARMA M. L., KHERDIKAR P. R., GREWAL R. S. Some observations on pecking in pigeons. Br J Pharmacol Chemother. 1961 Aug;17:7–11. doi: 10.1111/j.1476-5381.1961.tb01098.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Daly J. W. Adenosine receptors: targets for future drugs. J Med Chem. 1982 Mar;25(3):197–207. doi: 10.1021/jm00345a001. [DOI] [PubMed] [Google Scholar]
  9. Fredholm B. B., Fuxe K., Agnati L. Effect of some phosphodiesterase inhibitors on central dopamine mechanisms. Eur J Pharmacol. 1976 Jul;38(1):31–38. doi: 10.1016/0014-2999(76)90198-9. [DOI] [PubMed] [Google Scholar]
  10. Fuxe K., Ungerstedt U. Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists. Med Biol. 1974 Feb;52(1):48–54. [PubMed] [Google Scholar]
  11. Glowa J. R., Spealman R. D. Behavioral effects of caffeine, N6-(L-phenylisopropyl) adenosine and their combination in the squirrel monkey. J Pharmacol Exp Ther. 1984 Dec;231(3):665–670. [PubMed] [Google Scholar]
  12. Heffner T. G., Wiley J. N., Williams A. E., Bruns R. F., Coughenour L. L., Downs D. A. Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology (Berl) 1989;98(1):31–37. doi: 10.1007/BF00442002. [DOI] [PubMed] [Google Scholar]
  13. Katims J. J., Annau Z., Snyder S. H. Interactions in the behavioral effects of methylxanthines and adenosine derivatives. J Pharmacol Exp Ther. 1983 Oct;227(1):167–173. [PubMed] [Google Scholar]
  14. Kebabian J. W., Calne D. B. Multiple receptors for dopamine. Nature. 1979 Jan 11;277(5692):93–96. doi: 10.1038/277093a0. [DOI] [PubMed] [Google Scholar]
  15. Londos C., Cooper D. M., Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A. 1980 May;77(5):2551–2554. doi: 10.1073/pnas.77.5.2551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Snyder S. H. Adenosine as a neuromodulator. Annu Rev Neurosci. 1985;8:103–124. doi: 10.1146/annurev.ne.08.030185.000535. [DOI] [PubMed] [Google Scholar]
  17. Snyder S. H., Katims J. J., Annau Z., Bruns R. F., Daly J. W. Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci U S A. 1981 May;78(5):3260–3264. doi: 10.1073/pnas.78.5.3260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Vonvoigtlander P. F., Losey E. G., Triezenberg H. J. Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment. J Pharmacol Exp Ther. 1975 Apr;193(1):88–94. [PubMed] [Google Scholar]
  19. Waddington J. L., O'Boyle K. M. Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist. Pharmacol Ther. 1989;43(1):1–52. doi: 10.1016/0163-7258(89)90046-6. [DOI] [PubMed] [Google Scholar]
  20. Zarrindast M. R., Moghaddampour E. Opposing influences of D-1 and D-2 dopamine receptors activation on morphine-induced antinociception. Arch Int Pharmacodyn Ther. 1989 Jul-Aug;300:37–50. [PubMed] [Google Scholar]
  21. Zarrindast M. R., Poursoltan M. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine. Br J Pharmacol. 1989 Apr;96(4):843–848. doi: 10.1111/j.1476-5381.1989.tb11893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. van Calker D., Müller M., Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979 Nov;33(5):999–1005. doi: 10.1111/j.1471-4159.1979.tb05236.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES